187 related articles for article (PubMed ID: 15796179)
1. Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate.
Efferth T; Volm M
In Vivo; 2005; 19(1):225-32. PubMed ID: 15796179
[TBL] [Abstract][Full Text] [Related]
2. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
3. Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors.
Ciaccio PJ; Shen H; Jaiswal AK; Lyttle MH; Tew KD
Mol Pharmacol; 1995 Oct; 48(4):639-47. PubMed ID: 7476889
[TBL] [Abstract][Full Text] [Related]
4. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.
Hayes JD; Pulford DJ
Crit Rev Biochem Mol Biol; 1995; 30(6):445-600. PubMed ID: 8770536
[TBL] [Abstract][Full Text] [Related]
5. Role of antioxidant genes for the activity of artesunate against tumor cells.
Efferth T; Briehl MM; Tome ME
Int J Oncol; 2003 Oct; 23(4):1231-5. PubMed ID: 12964009
[TBL] [Abstract][Full Text] [Related]
6. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
Moscow JA; Townsend AJ; Cowan KH
Mol Pharmacol; 1989 Jul; 36(1):22-8. PubMed ID: 2747627
[TBL] [Abstract][Full Text] [Related]
7. Markedly decreased expression of glutathione S-transferase pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis.
Yokomizo A; Kohno K; Wada M; Ono M; Morrow CS; Cowan KH; Kuwano M
J Biol Chem; 1995 Aug; 270(33):19451-7. PubMed ID: 7642628
[TBL] [Abstract][Full Text] [Related]
8. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE
Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107
[TBL] [Abstract][Full Text] [Related]
9. Glutathione homeostasis in human hepatic cells: overexpression of gamma-glutamylcysteine synthetase gene in cell lines resistant to buthionine sulfoximine, an inhibitor of glutathione synthesis.
Tanaka T; Uchiumi T; Kohno K; Tomonari A; Nishio K; Saijo N; Kondo T; Kuwano M
Biochem Biophys Res Commun; 1998 May; 246(2):398-403. PubMed ID: 9610371
[TBL] [Abstract][Full Text] [Related]
10. Molecular modes of action of artesunate in tumor cell lines.
Efferth T; Sauerbrey A; Olbrich A; Gebhart E; Rauch P; Weber HO; Hengstler JG; Halatsch ME; Volm M; Tew KD; Ross DD; Funk JO
Mol Pharmacol; 2003 Aug; 64(2):382-94. PubMed ID: 12869643
[TBL] [Abstract][Full Text] [Related]
11. Importance of glutathione and associated enzymes in drug response.
Shen H; Kauvar L; Tew KD
Oncol Res; 1997; 9(6-7):295-302. PubMed ID: 9406235
[TBL] [Abstract][Full Text] [Related]
12. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
13. Factors determining sensitivity or resistance of tumor cell lines towards artesunate.
Sertel S; Eichhorn T; Sieber S; Sauer A; Weiss J; Plinkert PK; Efferth T
Chem Biol Interact; 2010 Apr; 185(1):42-52. PubMed ID: 20144594
[TBL] [Abstract][Full Text] [Related]
14. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
Yang WZ; Begleiter A; Johnston JB; Israels LG; Mowat MR
Mol Pharmacol; 1992 Apr; 41(4):625-30. PubMed ID: 1569917
[TBL] [Abstract][Full Text] [Related]
15. Benzo[a]pyrene-induced elevation of GSH level protects against oxidative stress and enhances xenobiotic detoxification in human HepG2 cells.
Lin T; Yang MS
Toxicology; 2007 Jun; 235(1-2):1-10. PubMed ID: 17416446
[TBL] [Abstract][Full Text] [Related]
16. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
17. Identification of glutathione S-transferase isozymes and gamma-glutamylcysteine synthetase as negative acute-phase proteins in rat liver.
Buetler TM
Hepatology; 1998 Dec; 28(6):1551-60. PubMed ID: 9828219
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
[TBL] [Abstract][Full Text] [Related]
19. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
Zhang T; Guan M; Jin HY; Lu Y
Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]